About Enveric
Enveric Biosciences is leveraging its discovery engine and intellectual property portfolio to identify and build the next generation of psychedelic and cannabinoid medicines for the mind and body. By harnessing the power of synthetic biology and chemistry, the company is optimizing what nature created to improve the human condition.
14
Patents Filed
2
Clinic-Ready Programs in Cancer
6
Industry-Leading Collaborations
Psychedelic Therapies
Enveric is focused on synthesizing novel, tailored and highly commercial derivative molecules based on classic psychedelics.
CBD Combinations
Enveric seeks to advance novel combinations of CBD with chemotherapeutic agents and immunotherapies.
Development Programs
Enveric has a robust pipeline with multiple data points expected in 2022 for radiodermatitis and glioblastoma.
